GenSight Biologics Issues Warrants in EUR 1 Million Fundraising
GenSight Biologics completed its EUR 1 million fundraising, announced October 8, 2026, issuing shares and warrants. The issuance included 11,940,300 pre-funded warrants exercisable for 11,940,300 additional ordinary shares. A further 14,537,704 investor warrants carry rights to subscribe for 7,268,852 additional ordina